medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2002, Number 3

<< Back Next >>

Ann Hepatol 2002; 1 (3)

Hepatic adenomatosis in an Hispanic patient. A case report and review of the literature

Montaño-Loza A, Ríos-Vaca A, Remes-Troche JM, Meza-Junco J, Trinidad-Hernández SP

Language: English
References: 20
Page: 136-139
PDF size: 210.31 Kb.


Text Extraction

Objective: Liver adenomatosis (LA) is a rare disease originally defined by Flejou et al. in 1985 from a series of 13 cases. Only 57 cases have been reported in the literature, and all have been documented among Caucasian population. The aim of this study is to review and reappraise the characteristics of this rare liver disease, and to discuss the diagnosis and therapeutic options. Background: LA is defined as the presence of › 10 adenomas in an otherwise normal liver parenchyma. Neither female predominance nor a relation with estrogen/progesterone intake has been noted. Natural progression is poorly understood. Methods: We describe the clinical presentation, evolution, radiologic studies, histologic characteristics and therapeutic options in a 3rd generation Mexican woman with LA. We also include an updated review of the literature. Results: The natural history and pathogenesis of LA are unclear. The risk of spontaneous hemorrhage or malignant transformation are a major concern. There is controversy regarding the optimal treatment for this disease; treatment options range from conservative medical therapy to surgical resection and even liver transplantation. Conclusion: LA is a rare disease, more common in women, and its outcome and evolution vary. Most often, conservative surgery is indicated. Liver transplantation is indicated only in highly symptomatic and aggressive forms of the disease.


REFERENCES

  1. Sale GE, Lerner KG. Multiple tumors after androgen therapy. Arch Pathol Lab Med 1977; 101: 600-3

  2. Westaby D, Portmann B, Williams R. Androgen related primary hepatic tumors in non-Fanconi patients. Cancer 1983; 51: 1947-52.

  3. Boyd PR, Mark GJ. Multiple hepatic adenomas and a hepatocelular carcinoma in a man on oral methyl testosterone for eleven years. Cancer 1977; 40: 1765-70.

  4. Howell RR, Stevenson RE, Menachem BY, et al. Hepatic adenomata with type I glycogen storage disease JAMA 1976; 236: 1481-4.

  5. Flejou JF, Barge J, Menu Y, et al. Liver adenomatosis: an entity distinct from liver adenoma? Gastroenterology 1985; 83: 1132-1138.

  6. Choi BI, Han JK, Kim SH, Han MC. MR findings in liver adenomatosis. Gastrointestinal Radiol 1991; 16: 234-46.

  7. Grazioli L, Federle MP, Ichikawa T, Balzano E, Nalesnik M, Madariaga J. Liver adenomatosis: clinical, histopathologic, and imaging findings in 15 patients. Radiology 2000; 216: 395-402.

  8. Bisson A, Duron JJ, Fagniez PL, Pinadeau Y, Germain A. Adenomatose hepatique et contraceptifs oraux: aspects chirurgicaux. Nour Presse Med 1974; 3: 2079-82.

  9. Chiche L, Dao Tephrem S, et al. Liver adenomatosis: reappraisal, diagnosis, and surgical management. Eigth new cases and review of the literature. Ann Surg 2000; 1: 74-81.

  10. Leese T, Farges O, Bismuth H. Liver cell adenomas: a 12-year surgical experience from a specialist hepato-biliary unit. Ann Surg 1988; 208: 558-64.

  11. Limmer J, Fleig WE, Leupold D, et al. Hepatocellular carcinoma in type I glycogen storage disease. Hepatology 1988; 8: 531-37.

  12. Lui AFK, Hiratzka LF, Hirose M. Multiple adenomas of the liver. Cancer 1989; 45: 1001-04.

  13. Arrive L, Fejou JF, Vilgrain V, et al. Hepatic adenoma: MR findings in 51 pathologically proved lesions. Radiology 1994; 193: 507-12.

  14. Kawakatsu M, Vilgrain VJ, Flejou FJ, Nahum H. Association of multiple liver cell adenomas with spontaneous intrahepatic portohepatic shunt. Abdom Imaging 1994; 19: 438-440.

  15. Motoori S, Shinozaki M, Goto N, Kondo F. Case report: congenital absence of the portal vein associated with nodular hyperplasia in the liver. J Gastroenterol Hepatol 1997; 12: 639-643.

  16. Yoshidome H. Management issues regarding hepatic adenomatosis. Am Surg 1999; 65: 1070-6.

  17. Arsenault TM, Johnson CD, Gorman B, Burgart LJ. Hepatic adenomatosis (case report). Mayo Clin Proc 1996; 71: 478-80.

  18. Zangeneh F, Limbeck GA, Brown BI, et al. Hepatorenal glycogenosis (type I glycogenosis) and carcinoma of the liver. J Pediatr 1969; 74: 73-83.

  19. Mathieu D, Bruneton JN, Drouillard J, Pointreau CC, Vasile N. Hepatic adenomas and focal hyperplasia: dynamic CT study. Radiology 1986; 160: 53-8.

  20. Welch TJ, Sheedy PF II, Johnson CM, et al. Focal nodular hyperplasia and hepatic adenoma: comparison of angiography, CT, US, and scintigraphy. Radiology 1985; 156: 593-95.




2020     |     www.medigraphic.com